Tradestie Institutional Equity Comparison Engine
FOFO vs ASTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ASTH Overall Edge
ASTH Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Astrana Health Inc. Common Stock (ASTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, FOFO trades at N/M Forward P/E with -823.6% operating margin (-72.7% YoY revenue) versus ASTH at 8.3x Forward P/E and 2.6% operating margin (+7.1% YoY). In options structure, FOFO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ASTH sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ASTH
FOFO N/M vs ASTH 8.3x Fwd P/E
Growth & Margin Winner
ASTH
Op Margin -823.6% vs 2.6% ยท YoY -72.7% vs +7.1%
Momentum & Technical Winner
ASTH
1Y -85.9% vs +31.2% ยท 52W Pos 0% vs 32%
Options & Structure Winner
ASTH
UNCLASSIFIED (N/A IV) vs BREAKDOWN (8th %ile IV)
FOFO
NASDAQ
Hang Feng Technology Innovation Co., Ltd. Ordinary Shares
Services-Management Consulting Services
$1.50
-7.41% 1D
Market Cap
$12.8M
1M Return
-23.86%
1Y Return
-85.89%
Forward P/E
N/M
Unified AI Score
43.0 / 100
HOLD
Tech 33.0
Fund 54.0
Flow 50.0
Mom 60.0
ASTH
NASDAQ
Astrana Health Inc. Common Stock
Services-Management Consulting Services
$28.90
+0.77% 1D
Market Cap
$1.4B
1M Return
-23.97%
1Y Return
+31.18%
Forward P/E
8.3x
Unified AI Score
48.8 / 100
HOLD
Tech 53.0
Fund 55.0
Flow 55.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FOFO -85.89%
ASTH +31.18%
Spread: +117.07 pp (ASTH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FOFO TTM Op. Margin: -823.6%
ASTH TTM Op. Margin: 2.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FOFO vs ASTH. Trailing 12-month operating profitability (FOFO -823.6% vs ASTH 2.6%) and valuation multiples (FOFO N/M vs ASTH 8.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FOFO | ASTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.8M | $1.4B | Larger Scale | ASTH |
| Trailing P/E Ratio Valuation | N/M | 26.6x | Lower Multiple | ASTH |
| Forward P/E Ratio Valuation | N/M | 8.3x | Lower Multiple | ASTH |
| Revenue Growth (YoY) Growth | -72.7% | +7.1% | Higher Growth | ASTH |
| Operating Margin (TTM) Profitability | -823.6% | 2.6% | Higher Margin | ASTH |
| Net Profit Margin Profitability | 0.0% | 1.4% | Higher Margin | ASTH |
| Return on Equity (ROE) Capital Efficiency | -169.2% | 9.8% | Higher ROE | ASTH |
| 52-Week Range Position Momentum | 0% ($2โ$15) | 32% ($18โ$52) | Stronger Trend | ASTH |
| Beta / 30D Volatility Risk Regime | 0.45ฮฒ ยท 65% Vol | 0.40ฮฒ ยท 60% Vol | Lower Realized Risk | ASTH |
| Unified Institutional Score Composite Signal | 43.0 / 100 (HOLD) | 48.8 / 100 (HOLD) | Higher Composite | ASTH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FOFO vs ASTH Buy Guide
FOFO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ASTH
BREAKDOWN
100d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FOFO nor ASTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.